Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labelled fibroblast activation protein inhibitor FAPI-04.

Varasteh Z, Mohanta S, Robu S, Braeuer M, Li Y, Omidvari N, Topping G, Sun T, Nekolla SG, Richter A, Weber C, Habenicht A, Haberkorn UA, Weber WA.

J Nucl Med. 2019 Aug 12. pii: jnumed.119.226993. doi: 10.2967/jnumed.119.226993. [Epub ahead of print]

PMID:
31405922
2.

PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function.

Bianchini M, Duchêne J, Santovito D, Schloss MJ, Evrard M, Winkels H, Aslani M, Mohanta SK, Horckmans M, Blanchet X, Lacy M, von Hundelshausen P, Atzler D, Habenicht A, Gerdes N, Pelisek J, Ng LG, Steffens S, Weber C, Megens RTA.

Sci Immunol. 2019 Jun 21;4(36). pii: eaar3054. doi: 10.1126/sciimmunol.aar3054.

PMID:
31227596
3.

Vascular Smooth Muscle Cells Contribute to Atherosclerosis Immunity.

Hu D, Yin C, Luo S, Habenicht AJR, Mohanta SK.

Front Immunol. 2019 May 17;10:1101. doi: 10.3389/fimmu.2019.01101. eCollection 2019. Review.

4.

Publisher Correction: ApoE attenuates unresolvable inflammation by complex formation with activated C1q.

Yin C, Ackermann S, Ma Z, Mohanta SK, Zhang C, Li Y, Nietzsche S, Westermann M, Peng L, Hu D, Bontha SV, Srikakulapu P, Beer M, Megens RTA, Steffens S, Hildner M, Halder LD, Eckstein HH, Pelisek J, Herms J, Roeber S, Arzberger T, Borodovsky A, Habenicht L, Binder CJ, Weber C, Zipfel PF, Skerka C, Habenicht AJR.

Nat Med. 2019 Mar;25(3):529. doi: 10.1038/s41591-019-0378-6.

PMID:
30718908
5.

ApoE attenuates unresolvable inflammation by complex formation with activated C1q.

Yin C, Ackermann S, Ma Z, Mohanta SK, Zhang C, Li Y, Nietzsche S, Westermann M, Peng L, Hu D, Bontha SV, Srikakulapu P, Beer M, Megens RTA, Steffens S, Hildner M, Halder LD, Eckstein HH, Pelisek J, Herms J, Roeber S, Arzberger T, Borodovsky A, Habenicht L, Binder CJ, Weber C, Zipfel PF, Skerka C, Habenicht AJR.

Nat Med. 2019 Mar;25(3):496-506. doi: 10.1038/s41591-018-0336-8. Epub 2019 Jan 28. Erratum in: Nat Med. 2019 Feb 4;:.

6.

Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 68Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques.

Varasteh Z, Mohanta S, Li Y, López Armbruster N, Braeuer M, Nekolla SG, Habenicht A, Sager HB, Raes G, Weber W, Hernot S, Schwaiger M.

EJNMMI Res. 2019 Jan 21;9(1):5. doi: 10.1186/s13550-019-0474-0.

7.

β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer.

Renz BW, Takahashi R, Tanaka T, Macchini M, Hayakawa Y, Dantes Z, Maurer HC, Chen X, Jiang Z, Westphalen CB, Ilmer M, Valenti G, Mohanta SK, Habenicht AJR, Middelhoff M, Chu T, Nagar K, Tailor Y, Casadei R, Di Marco M, Kleespies A, Friedman RA, Remotti H, Reichert M, Worthley DL, Neumann J, Werner J, Iuga AC, Olive KP, Wang TC.

Cancer Cell. 2018 Nov 12;34(5):863-867. doi: 10.1016/j.ccell.2018.10.010. No abstract available.

8.

Making the leap and finding your feet: A qualitative study of disclosure and social support in university students with type 1 diabetes.

Habenicht AE, Gallagher S, O'Keeffe MC, Creaven AM.

J Health Psychol. 2018 Nov 11:1359105318810875. doi: 10.1177/1359105318810875. [Epub ahead of print]

PMID:
30417701
9.

Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.

Williams JW, Martel C, Potteaux S, Esaulova E, Ingersoll MA, Elvington A, Saunders BT, Huang LH, Habenicht AJ, Zinselmeyer BH, Randolph GJ.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1702-1710. doi: 10.1161/ATVBAHA.118.311319.

10.

β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer.

Renz BW, Takahashi R, Tanaka T, Macchini M, Hayakawa Y, Dantes Z, Maurer HC, Chen X, Jiang Z, Westphalen CB, Ilmer M, Valenti G, Mohanta SK, Habenicht AJR, Middelhoff M, Chu T, Nagar K, Tailor Y, Casadei R, Di Marco M, Kleespies A, Friedman RA, Remotti H, Reichert M, Worthley DL, Neumann J, Werner J, Iuga AC, Olive KP, Wang TC.

Cancer Cell. 2018 Jan 8;33(1):75-90.e7. doi: 10.1016/j.ccell.2017.11.007. Epub 2017 Dec 14. Erratum in: Cancer Cell. 2018 Nov 12;34(5):863-867.

11.

Type-2 innate lymphoid cells control the development of atherosclerosis in mice.

Newland SA, Mohanta S, Clément M, Taleb S, Walker JA, Nus M, Sage AP, Yin C, Hu D, Kitt LL, Finigan AJ, Rodewald HR, Binder CJ, McKenzie ANJ, Habenicht AJ, Mallat Z.

Nat Commun. 2017 Jun 7;8:15781. doi: 10.1038/ncomms15781.

12.

Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept.

Varasteh Z, Hyafil F, Anizan N, Diallo D, Aid-Launais R, Mohanta S, Li Y, Braeuer M, Steiger K, Vigne J, Qin Z, Nekolla SG, Fabre JE, Döring Y, Le Guludec D, Habenicht A, Vera DR, Schwaiger M.

EJNMMI Res. 2017 Dec;7(1):40. doi: 10.1186/s13550-017-0287-y. Epub 2017 May 3.

13.

The Wilms tumor protein Wt1 contributes to female fertility by regulating oviductal proteostasis.

Nathan A, Reinhardt P, Kruspe D, Jörß T, Groth M, Nolte H, Habenicht A, Herrmann J, Holschbach V, Toth B, Krüger M, Wang ZQ, Platzer M, Englert C.

Hum Mol Genet. 2017 May 1;26(9):1694-1705. doi: 10.1093/hmg/ddx075.

14.

Editorial: Tertiary Lymphoid Organs (TLOs): Powerhouses of Disease Immunity.

Yin C, Mohanta S, Maffia P, Habenicht AJ.

Front Immunol. 2017 Mar 6;8:228. doi: 10.3389/fimmu.2017.00228. eCollection 2017. No abstract available.

15.

Artery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis Immunity.

Yin C, Mohanta SK, Srikakulapu P, Weber C, Habenicht AJ.

Front Immunol. 2016 Oct 10;7:387. eCollection 2016. Review.

16.

Aorta Atherosclerosis Lesion Analysis in Hyperlipidemic Mice.

Mohanta S, Yin C, Weber C, Hu D, Habenicht AJ.

Bio Protoc. 2016 Jun 5;6(11). pii: e1833.

17.

Preparation of Single Cell Suspensions from Mouse Aorta.

Hu D, Yin C, Mohanta SK, Weber C, Habenicht AJ.

Bio Protoc. 2016 Jun 5;6(11). pii: e1832.

18.

Artery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE-/- Mice.

Srikakulapu P, Hu D, Yin C, Mohanta SK, Bontha SV, Peng L, Beer M, Weber C, McNamara CA, Grassia G, Maffia P, Manz RA, Habenicht AJ.

Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1174-85. doi: 10.1161/ATVBAHA.115.306983. Epub 2016 Apr 21. Erratum in: Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):e62.

19.

Generation of Aorta Transcript Atlases of Wild-Type and Apolipoprotein E-null Mice by Laser Capture Microdissection-Based mRNA Expression Microarrays.

Yin C, Mohanta S, Ma Z, Weber C, Hu D, Weih F, Habenicht A.

Methods Mol Biol. 2015;1339:297-308. doi: 10.1007/978-1-4939-2929-0_20.

PMID:
26445797
20.

Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin β Receptors.

Hu D, Mohanta SK, Yin C, Peng L, Ma Z, Srikakulapu P, Grassia G, MacRitchie N, Dever G, Gordon P, Burton FL, Ialenti A, Sabir SR, McInnes IB, Brewer JM, Garside P, Weber C, Lehmann T, Teupser D, Habenicht L, Beer M, Grabner R, Maffia P, Weih F, Habenicht AJ.

Immunity. 2015 Jun 16;42(6):1100-15. doi: 10.1016/j.immuni.2015.05.015.

21.

Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis.

Mohanta SK, Yin C, Peng L, Srikakulapu P, Bontha V, Hu D, Weih F, Weber C, Gerdes N, Habenicht AJ.

Circ Res. 2014 May 23;114(11):1772-87. doi: 10.1161/CIRCRESAHA.114.301137. Review.

PMID:
24855201
22.

Hypothyroidism compromises hypothalamic leptin signaling in mice.

Groba C, Mayerl S, van Mullem AA, Visser TJ, Darras VM, Habenicht AJ, Heuer H.

Mol Endocrinol. 2013 Apr;27(4):586-97. doi: 10.1210/me.2012-1311. Epub 2013 Mar 21.

23.

Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity.

Gautier EL, Chow A, Spanbroek R, Marcelin G, Greter M, Jakubzick C, Bogunovic M, Leboeuf M, van Rooijen N, Habenicht AJ, Merad M, Randolph GJ.

J Immunol. 2012 Sep 1;189(5):2614-24. doi: 10.4049/jimmunol.1200495. Epub 2012 Aug 1.

24.

Control of dichotomic innate and adaptive immune responses by artery tertiary lymphoid organs in atherosclerosis.

Weih F, Gräbner R, Hu D, Beer M, Habenicht AJ.

Front Physiol. 2012 Jul 6;3:226. doi: 10.3389/fphys.2012.00226. eCollection 2012.

25.

Laser-capture microdissection of hyperlipidemic/ApoE⁻/⁻ mouse aorta atherosclerosis.

Beer M, Doepping S, Hildner M, Weber G, Grabner R, Hu D, Mohanta SK, Srikakulapu P, Weih F, Habenicht AJ.

Methods Mol Biol. 2011;755:417-28. doi: 10.1007/978-1-61779-163-5_35.

PMID:
21761324
26.

An integrative functional genomic and gene expression approach revealed SORBS2 as a putative tumour suppressor gene involved in cervical carcinogenesis.

Backsch C, Rudolph B, Steinbach D, Scheungraber C, Liesenfeld M, Häfner N, Hildner M, Habenicht A, Runnebaum IB, Dürst M.

Carcinogenesis. 2011 Jul;32(7):1100-6. doi: 10.1093/carcin/bgr093. Epub 2011 May 19.

PMID:
21602178
27.

Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling.

Lötzer K, Döpping S, Connert S, Gräbner R, Spanbroek R, Lemser B, Beer M, Hildner M, Hehlgans T, van der Wall M, Mebius RE, Lovas A, Randolph GJ, Weih F, Habenicht AJ.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):395-402. doi: 10.1161/ATVBAHA.109.191395. Epub 2010 Feb 5.

28.

Comparison of gene expression profiles between human and mouse monocyte subsets.

Ingersoll MA, Spanbroek R, Lottaz C, Gautier EL, Frankenberger M, Hoffmann R, Lang R, Haniffa M, Collin M, Tacke F, Habenicht AJ, Ziegler-Heitbrock L, Randolph GJ.

Blood. 2010 Jan 21;115(3):e10-9. doi: 10.1182/blood-2009-07-235028. Epub 2009 Nov 12. Erratum in: Blood. 2010 Aug 5;116(5):857.

29.

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice.

Gräbner R, Lötzer K, Döpping S, Hildner M, Radke D, Beer M, Spanbroek R, Lippert B, Reardon CA, Getz GS, Fu YX, Hehlgans T, Mebius RE, van der Wall M, Kruspe D, Englert C, Lovas A, Hu D, Randolph GJ, Weih F, Habenicht AJ.

J Exp Med. 2009 Jan 16;206(1):233-48. doi: 10.1084/jem.20080752. Epub 2009 Jan 12.

30.

High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes.

Mahshid Y, Lisy MR, Wang X, Spanbroek R, Flygare J, Christensson B, Björkholm M, Sander B, Habenicht AJ, Claesson HE.

BMC Immunol. 2009 Jan 9;10:2. doi: 10.1186/1471-2172-10-2.

31.

Differential RelA- and RelB-dependent gene transcription in LTbetaR-stimulated mouse embryonic fibroblasts.

Lovas A, Radke D, Albrecht D, Yilmaz ZB, Möller U, Habenicht AJ, Weih F.

BMC Genomics. 2008 Dec 16;9:606. doi: 10.1186/1471-2164-9-606.

32.

Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice.

Cao RY, St Amand T, Gräbner R, Habenicht AJ, Funk CD.

Atherosclerosis. 2009 Apr;203(2):395-400. doi: 10.1016/j.atherosclerosis.2008.07.045. Epub 2008 Aug 15.

PMID:
18804760
33.

5-Lipoxygenase/cyclooxygenase-2 cross-talk through cysteinyl leukotriene receptor 2 in endothelial cells.

Lötzer K, Jahn S, Kramer C, Hildner M, Nüsing R, Funk CD, Habenicht AJ.

Prostaglandins Other Lipid Mediat. 2007 Nov;84(3-4):108-15. Epub 2007 Apr 27.

PMID:
17991613
34.

Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice.

Cao RY, Adams MA, Habenicht AJ, Funk CD.

Prostaglandins Other Lipid Mediat. 2007 Aug;84(1-2):34-42. Epub 2007 Mar 24.

PMID:
17643886
35.

Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy.

Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A, Clausen BE, Stride B, Förster I, Habenicht AJ, Reichardt HM, Tronche F, Schmid W, Schütz G.

J Clin Invest. 2007 May;117(5):1381-90. Epub 2007 Apr 19.

36.

Selective 5-lipoxygenase expression in Langerhans cells and impaired dendritic cell migration in 5-LO-deficient mice reveal leukotriene action in skin.

Doepping S, Funk CD, Habenicht AJ, Spanbroek R.

J Invest Dermatol. 2007 Jul;127(7):1692-700. Epub 2007 Mar 29.

37.

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ.

J Clin Invest. 2007 Jan;117(1):185-94.

38.
39.

What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?

Fürstenberger G, Krieg P, Müller-Decker K, Habenicht AJ.

Int J Cancer. 2006 Nov 15;119(10):2247-54. Review.

40.

Analysis of the 5-lipoxygenase promoter and characterization of a vitamin D receptor binding site.

Sorg BL, Klan N, Seuter S, Dishart D, Rådmark O, Habenicht A, Carlberg C, Werz O, Steinhilber D.

Biochim Biophys Acta. 2006 Jul;1761(7):686-97. Epub 2006 Apr 26.

PMID:
16750418
41.

Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells.

Uzonyi B, Lötzer K, Jahn S, Kramer C, Hildner M, Bretschneider E, Radke D, Beer M, Vollandt R, Evans JF, Funk CD, Habenicht AJ.

Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6326-31. Epub 2006 Apr 10.

42.

The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice.

Moos MP, John N, Gräbner R, Nossmann S, Günther B, Vollandt R, Funk CD, Kaiser B, Habenicht AJ.

Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2386-91. Epub 2005 Sep 22.

PMID:
16179593
43.

Jumping nanodroplets.

Habenicht A, Olapinski M, Burmeister F, Leiderer P, Boneberg J.

Science. 2005 Sep 23;309(5743):2043-5.

44.

The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis.

Lötzer K, Funk CD, Habenicht AJ.

Biochim Biophys Acta. 2005 Sep 5;1736(1):30-7. Review.

PMID:
16081317
45.

Quantum features in atomic nanofabrication using exactly resonant standing waves.

Jürgens D, Greiner A, Stützle R, Habenicht A, te Sligte E, Oberthaler MK.

Phys Rev Lett. 2004 Dec 3;93(23):237402. Epub 2004 Nov 29.

PMID:
15601201
46.

The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm.

Zhao L, Moos MP, Gräbner R, Pédrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lötzer K, Huang L, Cui J, Rader DJ, Evans JF, Habenicht AJ, Funk CD.

Nat Med. 2004 Sep;10(9):966-73. Epub 2004 Aug 22.

47.

The potential role of antileukotriene drugs in atherosclerosis.

Spanbroek R, Habenicht AJ.

Drug News Perspect. 2003 Oct;16(8):485-9. Review.

PMID:
14668944
48.

Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells.

Bretschneider E, Spanbroek R, Lötzer K, Habenicht AJ, Schrör K.

Thromb Haemost. 2003 Oct;90(4):704-9.

PMID:
14515192
49.

Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis.

Lötzer K, Spanbroek R, Hildner M, Urbach A, Heller R, Bretschneider E, Galczenski H, Evans JF, Habenicht AJ.

Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):e32-6. Epub 2003 Jun 19.

PMID:
12816882
50.

Amino acid differences in the deduced 5-lipoxygenase sequence of CAST atherosclerosis-resistance mice confer impaired activity when introduced into the human ortholog.

Kuhn H, Anton M, Gerth C, Habenicht A.

Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):1072-6. Epub 2003 May 1.

PMID:
12730086

Supplemental Content

Loading ...
Support Center